Pharma ingredient maker Sequent Scientific today said it will invest Rs 150 crore in expansion plans, which include foraying into new therapeutic segment and setting up of greenfield facilities.
The company in a statement said that it will invest Rs 150 crore in the next two years in expanding its presence to three new therapeutic areas.
It, however, did not provide the details regarding the sourcing of the investments.
"Expansion into new therapeutic segments will not only enable the company's presence in high growth high margin segment but would also strengthen its product portfolio," Sequent Chairman and Managing Director K R Ravishankar said.
The company said it has signed a memorandum of understanding (MoU) with the Karnataka government for setting up three manufacturing facilities in Bangalore.